Very quick/hurried notes from question time... feel free to add;
ADAPT portfolio hitting internal growth targets? “You bet it is”
Future growth targets are still expected to be hit.
$1 million in consumables for Adelaide Hospital. May ‘throw $50k at sales team to take up the slack”
ROI for immunotherapies? “We could move to Phase III based on 58% viral shedding” i.e. we are still on a commercial pathway for HSV-2
Restructuring costs for code red completed? “I think for the most part”
Will the cash balance be topped up from loan? “I will not have a capital raising. We now have a business strategy. There are certainly means and ways to obtain funding without diluting shareholders.”
30% reduction across the board in personnel numbers. He’s not sure what it means in salaries (“we don’t have the data yet”).
The board has a very clear plan on future funding. “We will share that with you as we are able”.
“I know of at least 3 or 4 multi-year contracts that are coming to fruition now.” I think he mentioned “Stanford”?
Cashflow positive – “I’m comfortable we are on track re: previous targets”
(missed something here… anyone?)
Biggest revenue market will be North America, then Europe, then emerging markets
Prof Frazer results in April
Board has ambitions for share price over $2 (although he stressed he can't give forward-looking promises on share price).
Has recently distributed the book “Art of War” by Sun Tzu to the board members
AHZ Price at posting:
32.5¢ Sentiment: Hold Disclosure: Held
